The association between gastroesophageal reflux disease and interstitial lung fibrosis in systemic sclerosis
- Authors: Sosnovskaya A.V1, Fomin V.V1, Lebedeva M.V1, Popova E.N1, Muhin N.A1
-
Affiliations:
- I.M.Sechenov First Moscow State Medical University
- Issue: Vol 17, No 12 (2015)
- Pages: 73-76
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94416
- ID: 94416
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. V Sosnovskaya
I.M.Sechenov First Moscow State Medical University
Email: antonina.sosnovskaya@live.de
аспирант каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
V. V Fomin
I.M.Sechenov First Moscow State Medical University
Email: fomin_vic@mail.ru
д-р мед. наук, проф. каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического фак-та, проректор по лечебной работе ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
M. V Lebedeva
I.M.Sechenov First Moscow State Medical University
Email: marinaamica@mail.ru
канд. мед. наук, доц. каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
E. N Popova
I.M.Sechenov First Moscow State Medical University
Email: ela12@yandex.ru
д-р мед. наук, проф. каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
N. A Muhin
I.M.Sechenov First Moscow State Medical University
Email: mukhin-nephro@yandex.ru
акад. РАН, д-р мед. наук, проф., зав. каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического фак-та, дир. НОКЦ здоровьесберегающих технологий ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
References
- Ревматология: национальное руководство. Под ред. Е.Л.Насонова, В.А.Насоновой. М.: ГЭОТАР-Медиа, 2010.
- Коган Е.А., Коренев Б.М., Попова Е.Н. и др. Интерстициальные болезни легких. М.: Литтерра, 2007; с. 186-91.
- Ананьева Л.П., Теплова Л.В., Лесняк В.Н. и др. Клиническая оценка проявлений интерстициального поражения легких при системной склеродермии по данным компьютерной томографии высокого разрешения. Науч. - практ. ревматология. 2011; 2: 30-9.
- Гусева Н.Г. Системная склеродермия: клиника, диагностика, лечение. Рос. журн. кожных и венерических болезней. 2002; 4: 5-15.
- Насонова В.А., Астапенко М.Г. Клиническая ревматология. М.: Медицина, 1989; с. 175-93.
- Чучалин А.Г. Клинические рекомендации. Пульмонология. М.: ГЭОТАР-Медиа, 2007; с. 1-37.
- Гриппи М.А. Патофизиология легких. М.: Бином, 2005; с. 130-41.
- Bassotti G, Battaglia E, Debernardi V et al. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 1997; 40: 2252-9.
- Bouros D, Wells A.U, Nicholson A.G et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165 (12): 1581-6.
- Christmann R.B, Wells A.U, Capelozzi V.L, Silver R.M. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
- Clements P, Goldin J, Kleerup E et al. Regional differences in bronchoalveolar lavage and thoracic high - resolution computed tomography results in dyspno patients with systemic sclerosis. Arthr Rheum 2004; 50: 1909-17.
- De Souza R.B, Borges C.T, Capelozzi V.L et al. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis. Respiration 2009; 77 (4): 389-97.
- Desai S.R, Veeraraghavan S, Hansell D.M et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232 (2): 560-7.
- Downing T.E, Sporn T.A, Bollinger R.R et al. Pulmonary histopathology in an experimental model of chronic aspiration is independent of acidity. Exp Biol Med (Maywood) 2008; 1202-12.
- Ebert E.C. Esophageal disease in scleroderma. J Clin Gastroenterol 2006; 40: 769-75.
- Ebert E.C. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol 2008; 42: 5-12.
- Geirsson A.J, Wollheim F.A, Akesson A. Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis 2001; 60 (12): 1117-22.
- Gilson M, Zerkak D, Wipff J et al. Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases. Eur Respir J 2010; 35 (1): 112-7.
- Goh N.S, Desai S.R, Veeraraghavan S et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177 (11): 1248-54.
- Goldin J.G, Lynch D.A, Strollo D.C et al. High - resolution CT scan findings in patients with symptomatic scleroderma - related interstitial lung disease. Chest 2008; 134 (2): 358-67.
- Greenwald G.I, Tashkin D.P, Gong H et al. Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study. Am J Med 1987; 83 (1): 83-92.
- Guttadauria M, Ellman H, Emmanuel G et al. Pulmonary function in scleroderma. Arthritis Rheum 1977; 20: 1071-9.
- Harrison N.K, Myers A.R, Corrin B et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144 (3 Pt 1): 706-13.
- Highland K.B, Silver R.M. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Rheumatol 2005; 7 (2): 135-41.
- Ioannidis J.P, Vlachoyiannopoulos P.G, Haidich A.B et al. Mortality in systemic sclerosis: an international meta - analysis of individual patient data. Am J Med 2005; 118: 2-10.
- Jaffin B.W, Chang P, Spiera H. Fecal incontinence inscleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications. J Clin Gastroenterol 1997; 25: 513-7.
- Kaloudi О, Miniati I, Alari S. Interstitial lung disease in systemic sclerosis. Intern Emerg Med 2007; 2 (4): 250-5.
- Kay L, Jorgensen T, Jensen K.H. The epidemiology ofirritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994; 236: 23-30.
- Khanna D, Clements P.J, Furst D.E, Tashkin D.P. Current concepts in disease - modifying therapy for systemic sclerosis - associated interstitial lung disease: lessons from clinical trials. Curr Rheumatol Rep 2009; 11: 111-9.
- Khanna D, Hays R.D, Park G.S et al. Development of a preliminary scleroderma gastrointestinal tract 1.0 Quality of Life Instrument. Arthritis Rheum 2007; 57: 1280-6.
- Kim D.S, Yoo В, Lee J.S et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vase Diffuse Lung Dis 2002; 19 (2): 121-7.
- Lahcene M, Oumnia N, Matougui N et al. Esophageal dysmotility is scleroderma: a prospective study of 183 cases. Gastroenterol Clin Biol 2009; 33: 466-9.
- Marcisz C, Kucharz E.J, Brzezinska-Wcislo L et al. Pulmonary functional abnormalities in asymptomatic patients with systemic sclerosis. Eur J Intern Med 2003; 14 (3): 162-5.
- Marie I, Dominique S, Levesque H et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001; 45: 346-54.
- Mc Nearney T.A, Reveille J.D, Fischbach M et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthr Rheum 2007; 57 (2): 318-26.
- Morgan С, Knight С, Lunt M et al. Predictors of end stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 2003; 62 (2): 146-50.
- Nishimagi E, Tochimoto A, Kawaguchi Y et al. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 2007; 34: 2050-5.
- Nora M Thoua et al. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology (Oxford) 2010.
- Parra E.R, Otani L.H, de Carvalho E.F et al. Systemic sclerosis and idiopathic interstitial pneumonia: histomorphometric differences in lung biopsies. J Bras Pneumol 2009; 35 (6): 529-40.
- Peters-Golden M, Wise R.A, Schneider P et al. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine Baltimore 1984; 63 (4): 221-31.
- Remy-Jardin M, Remy J, Wallaert B. Pulmonary involvement in progressive systemic sclerosis sequential evaluation with CT, pulmonary tests and broncho - alveolar lavage. Radiology 1993; 188: 499-506.
- Ruangjutipopan S, Kasitanon N, Louthrenoo W et al. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thai 2002; 85 (11): 1204-9.
- Sallam H, Mc Nearney T.A, Chen J.D. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006; 23: 691-712.
- Savarino E, Bazzica M, Zentilin P et al. Gastroesophagealreflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009; 179: 408-13.
- Schurawitzki H, Stiglbauer R, Graninger W et al. Interstitial lung disease in progressive systemic sclerosis: high - resolution CT versus radiography. Radiology 1990; 176 (3): 755-9.